Cavernous sinus meningiomas: a large LINAC radiosurgery series.
One hundred and seventeen patients with cavernous sinus meningiomas had LINAC radiosurgery at our institution in the period 1993-2007. Six cases were lost and 9 had less than 1 year follow up. The remaining 102 patients were prospectively followed up at 1 y intervals with clinical, neuro-ophthalmological and MRI examinations. Patients' age ranged between 31 and 86 years (mean 57). Seventy percent were females. The mean tumor volume was 7 cc. Thirty-three patients had previous microsurgery. Tumors were defined with high resolution MRI obtained 1-2 days before treatment and fused to stereotactic CT. Treatment was mostly delivered through a minimultileaf collimator and multiple dynamic arcs. The minimal dose to the tumor margin was 12-17.5 Gy (mean 13.5) encompassed by the 80% isodose shell. Radiation dose to the optic apparatus was kept below 10 Gy. Follow up ranged from 12 to 180 months (mean 67 months). Tumor control (lack of growth) was 98% (58% of the tumors reduced their volumes). Sixty-four patients presented with cranial nerve deficit. Thirty-nine percent improved or resolved following radiosurgery. Cranial neuropathy had significantly higher resolution rates when radiosurgery was performed early (<1 year) after its appearance (53% as opposed to 26%) even in patients with deficits post surgery. Complications were seen in five patients (1 with deafferentation pain, 1 with facial hypesthesia, 1 with visual loss and 2 with partial VI neuropathy). Radiosurgery had a high control rate for meningiomas of the cavernous sinus with few and mild complications. Cranial neuropathy can be solved by treatment, particularly those of recent onset.
Spiegelmann
Roberto
R
Department of Neurosurgery, The Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel. Spiegel@sheba.health.gov.il
Cohen
Zvi R
ZR
Nissim
Ouzi
O
Alezra
Dror
D
Pfeffer
Raphael
R
D002426:Cavernous Sinus / Q000601:surgery*; D003389:Cranial Nerve Diseases / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005682:Gadolinium; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008577:Meningeal Neoplasms / Q000473:pathology* / Q000601:surgery*; D008579:Meningioma / Q000473:pathology* / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology; D016634:Radiosurgery / Q000379:methods*; D012189:Retrospective Studies; D016896:Treatment Outcome
D005682:Gadolinium
J Neurosurg. 2000 Dec;93 Suppl 3:68-73
11143266
J Neurosurg. 1996 Jan;84(1):20-8
8613831
J Neurosurg. 1994 Aug;81(2):245-51
8027808
Br J Neurosurg. 1996 Oct;10(5):439-44
8922701
Neurosurgery. 1996 Mar;38(3):434-42; discussion 442-4
8837793
Neurosurgery. 1996 Nov;39(5):915-9; discussion 919-20
8905745
Stereotact Funct Neurosurg. 2009;87(2):120-7
19246961
J Neurosurg. 1995 Oct;83(4):596-9
7545742
Neurosurgery. 2003 Mar;52(3):517-24; discussion 523-4
12590675
Neurosurgery. 2001 Nov;49(5):1029-37; discussion 1037-8
11846894
Neurosurgery. 1992 Jul;31(1):2-12
1641106
Neurosurgery. 2002 Dec;51(6):1373-79; discussion 1379-80
12445342
Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):215-21
8407394
Head Neck. 2001 Sep;23(9):780-4
11505489
J Neurosurg. 1983 Jun;58(6):824-31
6854374
Neurosurgery. 1997 Feb;40(2):238-44; discussion 245-7
9007855
Neurosurgery. 1995 Jul;37(1):1-9; discussion 9-10
8587667
J Neurosurg. 2002 Jul;97(1):65-72
12134934
J Neurosurg. 2007 Oct;107(4):745-51
17937218
Neurosurg Focus. 2003 Jun 15;14(6):e3
15669788
Neurosurgery. 2001 Feb;48(2):285-94; discussion 294-6
11220370
J Neurosurg. 2007 Nov;107(5):937-44
17977264
Neurosurgery. 2002 Nov;51(5):1153-9; discussion 1159-61
12383360
J Neurosurg. 1994 Aug;81(2):252-5
8027809